Evidence map›Paper›PMID 32098269›Full record

ArticleInternational journal of molecular sciences2020

Small Molecule Anion Carriers Correct Abnormal Airway Surface Liquid Properties in Cystic Fibrosis Airway Epithelia.

Ambra Gianotti, Valeria Capurro, Livia Delpiano, Marcin Mielczarek, María García-Valverde, Israel Carreira-Barral, Alessandra Ludovico, Michele Fiore, Debora Baroni, Oscar Moran and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Lysosome-Targeted Squaramide Anion Transporters.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Heterocyclic-Fused Squaramides: Anionophores With Antimicrobial Activity.Chembiochem : a European journal of chemical biology · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Recent Advances in Bioactive Artificial Ionophores.Chembiochem : a European journal of chemical biology · 2021
    Review
  11. New Therapies to Correct the Cystic Fibrosis Basic Defect.International journal of molecular sciences · 2021
    Review
  12. Hyperinflammation and airway surface liquid dehydration in cystic fibrosis: purinergic system as therapeutic target.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Review
  13. Transmembrane Transport of Bicarbonate Unravelled*.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Editorial: Special Issue on "Therapeutic Approaches for Cystic Fibrosis".International journal of molecular sciences · 2020
    Article
  20. Immunomodulation in Cystic Fibrosis: Why and How?International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Ambra GianottiUOC Genetica Medica, IRCSS Istituto Giannina Gaslini, 16145 Genova, Italy.
Valeria CapurroUOC Genetica Medica, IRCSS Istituto Giannina Gaslini, 16145 Genova, Italy.
Livia DelpianoUOC Genetica Medica, IRCSS Istituto Giannina Gaslini, 16145 Genova, Italy.
Marcin MielczarekDepartamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain.
María García-ValverdeDepartamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain.
Israel Carreira-BarralDepartamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain.
Alessandra LudovicoIstituto di Biofisica, Consiglio Nazionale Delle Ricerche (CNR), 16149 Genova, Italy.
Michele FioreIstituto di Biofisica, Consiglio Nazionale Delle Ricerche (CNR), 16149 Genova, Italy.
Debora BaroniIstituto di Biofisica, Consiglio Nazionale Delle Ricerche (CNR), 16149 Genova, Italy.
Oscar MoranIstituto di Biofisica, Consiglio Nazionale Delle Ricerche (CNR), 16149 Genova, Italy.
Roberto QuesadaDepartamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain.
Emanuela CaciUOC Genetica Medica, IRCSS Istituto Giannina Gaslini, 16145 Genova, Italy.
Instituto di Biofisica · ESIstituto Giannina Gaslini · ITUniversidad de Burgos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic fibrosis (CF) is a genetic disease characterized by the lack of cystic fibrosis transmembrane conductance regulator (CFTR) protein expressed in epithelial cells. The resulting defective chloride and bicarbonate secretion and imbalance of the transepithelial homeostasis lead to abnormal airway surface liquid (ASL) composition and properties. The reduced ASL volume impairs ciliary beating with the consequent accumulation of sticky mucus. This situation prevents the normal mucociliary clearance, favouring the survival and proliferation of bacteria and contributing to the genesis of CF lung disease. Here, we have explored the potential of small molecules capable of facilitating the transmembrane transport of chloride and bicarbonate in order to replace the defective transport activity elicited by CFTR in CF airway epithelia. Primary human bronchial epithelial cells obtained from CF and non-CF patients were differentiated into a mucociliated epithelia in order to assess the effects of our compounds on some key properties of ASL. The treatment of these functional models with non-toxic doses of the synthetic anionophores improved the periciliary fluid composition, reducing the fluid re-absorption, correcting the ASL pH and reducing the viscosity of the mucus, thus representing promising drug candidates for CF therapy.

Indexed as

IonophoresCell LineCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorEpithelial CellsHumansIon TransportMucusRespiratory MucosaCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorIonophoresanionophorebronchial epithelial cells culturecystic fibrosision transportpericiliar mucus properties

Identifiers

PMID32098269
PMCPMC7073096
OpenAlexW3008185087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.